Brian Golden, MD

I recently completed my 500th robotic case! Since training on the ol' standard daVinci robot, which now seems like a model T, I have used each improved iteration many times. Currently I get to operate using the latest and greatest, daVinci Xi. While this is really quite a fancy $2-million machine, I am looking forward to the upcoming introduction of the new Single Port platform.

UroLift is a tremendous improvement in the treatment of the obstructive prostate. Better than years on Meds?

The UroLift Procedure was recently featured on a national medical TV show. UroLift is a fantastic option for most men with obstructive voiding due to BPH. This is now my go-to procedure, often chosen instead of being on medication for years on end!

The unexpected medical benefit of Roller Coasters. Should kidney stone patients buy season passes to amusement parks?

E.D. is a common problem that becomes more common after prostate cancer treatment. Is Erexon gel going to give men with this problem the boost they need?

I spent the evening with Ted Lamson, founder, creator, and chief technical officer of Neotract and the UroLift device. After doing about 20 of these procedures, I am convinced this minimally invasive procedure will change how BPH is treated. http://urolift.com/urolift-system

At AUA 2016 - There are a lot of advances in Robotic surgery on the horizon. @Will the new Google +JNJ partnership advance the field of surgical robotics? Or will Intuitive Surgical push the envelope fast enough to stay on top?

Prostate Cancer Guinea Pigs

Microbiology lab starts at 0:36

I spent the afternoon training on the newest robotic surgery platform, the da Vinci Xi. I'm looking forward to operating with the new machine in about 2 weeks. Kudos to Sutter for being among the first in the nation to make the upgrade.

This brief video gives an inkling of the possible with the next iteration of robotic surgery utilizing a single incision. "LESS" - Laparoendoscopic Single Site.

Understanding of potentially lethal prostate cancer is progressing more rapidly. The ability to stratify our patients by risk would allow us to treat those who really need it ASAP, while preventing overtreatment of those with lower risk of a bad outcome.